Cannabis finance news

Company news: Emyria; Incannex; Epsilon; AusCann

by Martin Lane March 8, 2022April 29, 2024

Emyria Emyria has received ethics approval for a Phase 1 clinical trial of ultra-pure oral CBD […]

Company news: Cann Global; Incannex; Creso Pharma; Rua Bioscience; Avecho; InhaleRx; Greenfern Industries; MGC Pharma

by cannabiz team March 3, 2022April 29, 2024

LGP reports A$8.6m loss amid multi-million dollar R&D program while revenue jumps 94%

by Steve Jones March 1, 2022April 29, 2024

Emyria losses deepen as drug development takes centre stage

by Steve Jones March 1, 2022April 29, 2024

Oliver Horn - Cannabis News Australia - Cannabiz

All options on the table for Elixinol as losses narrow by 50%

by Martin Lane February 28, 2022April 29, 2024

Cronos to explore further acquisitions as merged group reports A$3.4m profit

by Steve Jones February 26, 2022April 29, 2024

Cannim completes Medisun merger, expands Australian product range

by Martin Lane February 25, 2022April 29, 2024

Creso Pharma raises A$5m ahead of US expansion

by Martin Lane February 25, 2022April 29, 2024

Zelira to acquire medicinal cannabis distributor Health House International

by Steve Jones February 24, 2022April 29, 2024

josh fegan

Company news: Althea; Bod; ECS Botanics; LGP; Live Verdure; Creso Pharma; Emyria; Medlab

by Martin Lane February 24, 2022April 29, 2024